Gut-associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation

Annals of the New York Academy of Sciences

Volumn 1207, Issue SUPPL.1, 2010, Pages

  Koboziev, Iurii ^a   Karlsson, Fridrik ^a   Grisham, Matthew B ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Crohn's disease; Inflammatory bowel disease; Integrins; Isolated lymphoid follicles; Lymphotoxin; Mesenteric lymph nodes; Peyer's patches; Selectins; Ulcerative colitis

Indexed keywords

ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; L SELECTIN; TUMOR NECROSIS FACTOR ALPHA;

CD4+ T LYMPHOCYTE; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; EFFECTOR CELL; ENTERITIS; HUMAN; INTESTINE; INTESTINE LYMPHATIC TISSUE; LYMPH FOLLICLE; LYMPH NODE; MESENTERY LYMPH NODE; NONHUMAN; PEYER PATCH; REVIEW; T LYMPHOCYTE; TH1 CELL; TH17 CELL; ANIMAL; CELL MOTION; CHRONIC DISEASE; COLITIS; LYMPHOID TISSUE; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; CELL MOVEMENT; CHRONIC DISEASE; COLITIS; HUMANS; LYMPHOID TISSUE; T-LYMPHOCYTES;

EID: 78049498890     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05711.x     Document Type: Review

References (47)

1. Blumberg, R.S. 2009. Inflammation in the intestinal tract: pathogenesis and treatment. Dig. Dis. 27: 455-464.
2. Kaser, A., S. Zeissig & R.S. Blumberg. 2010. Inflammatory bowel disease. Annu. Rev. Immunol. 28: 573-621.
3. Powrie, F. 1995. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 3: 171-174.
4. Powrie, F., S. Read, C.Mottet, et al. 2003.Control of immune pathology by regulatory T cells.Novartis. Found. Symp. 252: 92-98.
5. Uhlig, H.H. & F. Powrie. 2005. The role of mucosal T lymphocytes in regulating intestinal inflammation. Springer Semin. Immunopathol. 27: 167-180.
6. Elson, C.O., Y. Cong, V.J. McCracken, et al. 2005. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol. Rev. 206: 260-276.
7. Agace, W.W. 2008. T-cell recruitment to the intestinal mucosa. Trends Immunol. 29: 514-522.
8. Mueller, D.L. 2010.Mechanisms maintaining peripheral tolerance. Nat. Immunol. 11: 21-27.
9. Coombes, J.L. & F. Powrie. 2008. Dendritic cells in intestinal immune regulation. Nat. Rev. Immunol. 8: 435-446.
10. Kwa, S.F., P. Beverley & A.L. Smith. 2006. Peyer's patches are required for the induction of rapid Th1 responses in the gut and mesenteric lymph nodes during an enteric infection. J. Immunol. 176: 7533-7541.
11. Macpherson, A.J. & T. Uhr. 2004. Compartmentalization of the mucosal immune responses to commensal intestinal bacteria. Ann. N.Y. Acad. Sci. 1029: 36-43.
12. Macpherson, A.J.&K. Smith. 2006.Mesenteric lymph nodes at the center of immune anatomy. J. Exp.Med. 203: 497-500.
13. Mowat, A.M. 2003. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3: 331-341.
14. Mowat, A.M., O.R.Millington&F.G. Chirdo. 2004.Anatomical and cellular basis of immunity and tolerance in the intestine. J. Pediatr. Gastroenterol. Nutr. 39(Suppl 3): S723-S724.
15. Forster, R., O. Pabst & G. Bernhardt. 2008. Homeostatic chemokines in development, plasticity, and functional organization of the intestinal immune system. Semin. Immunol. 20: 171-180.
16. Malmstrom, V., D. Shipton, B. Singh, et al. 2001. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J. Immunol. 166: 6972-6981.
17. Weaver, C.T., R.D. Hatton, P.R. Mangan & L.E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852.
18. Yen, D., J. Cheung, H.Scheerens, et al. 2006. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest 116: 1310-1316.
19. von Andrian, U.H.&C.R.Mackay. 2000. T-cell function and migration. Two sides of the same coin. N. Engl. J. Med. 343: 1020-1034.
20. Luster, A.D., R. Alon&U.H. vonAndrian. 2005. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6: 1182-1190.
21. Mora, J.R. 2008. Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids. Inflamm. Bowel. Dis. 14: 275-289.
22. von Andrian, U.H. 2004. Adhesion and communication between lymphocytes and endothelial cells. In Molecular Basis forMicrocirculatoryDisorders.G.W. Schmid-Schonbein, GW Ed.: 101-137. Springer, Paris.
23. von Andrian, U.H. & T.R. Mempel. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3: 867-878.
24. Sans, M., J. Panes, E.Ardite, et al. 1999.VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis. Gastroenterology 116: 874-883.
25. Sans, M., A. Salas, A. Soriano, et al. 2001. Differential role of selectins in experimental colitis. Gastroenterology 120: 1162-1172.
26. Steeber, D.A., M.L. Tang, X.Q. Zhang, et al. 1998. Efficient lymphocyte migration across high endothelial venules of mouse Peyer's patches requires overlapping expression of L-selectin and beta7 integrin. J. Immunol. 161: 6638-6647.
27. Tang, M.L., L.P. Hale, D.A. Steeber & T.F. Tedder. 1997. L-selectin is involved in lymphocyte migration to sites of inflammation in the skin: delayed rejection of allografts in L-selectin-deficient mice. J. Immunol. 158: 5191-5199.
28. Xu, L., A. Kitani, I. Fuss & W. Strober. 2007. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 178: 6725-6729.
29. Zhang, X.W., Q. Liu &H. Thorlacius. 2001. Inhibition of selectin function and leukocyte rolling protects against dextran sodium sulfate-induced murine colitis. Scand. J. Gastroenterol. 36: 270-275.
30. Ostanin, D.V., K.L. Furr, K.P. Pavlick, et al. 2007. T cellassociated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1706-G1714.
31. Ostanin, D.V., J. Bao, I. Koboziev, L. Gray. et al. 2009. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am. J. Physiol. Gastrointest Liver Physiol. 296: G135-G146.
32. Abdelbaqi, M., J.H. Chidlow, K.M. Matthews, et al. 2006. Regulation of dextran sodium sulfate induced colitis by leukocyte beta 2 integrins. Lab Invest. 86: 380-390.
33. Pavlick, K.P., D.V. Ostanin, K.L. Furr, et al. 2006. Role of T-cell-associated lymphocyte function-associated antigen-1 in the pathogenesis of experimental colitis. Int. Immunol. 18: 389-398.
34. Sydora, B.C., N.Wagner, J. Lohler, et al. 2002. beta7 Integrin expression is not required for the localization of T cells to the intestine and colitis pathogenesis. Clin. Exp. Immunol. 129: 35-42.
35. Rivera-Nieves, J., T. Olson, G. Bamias, et al. 2005. L-selectin, alpha 4 beta 1, and alpha 4 beta 7 integrins participate in CD4+ T cell recruitment to chronically inflamed small intestine. J. Immunol. 174: 2343-2352.
36. Bjursten, M., P.W. Bland, R. Willen & E.H. Hornquist. 2005. Long-term treatment with anti-alpha 4 integrin antibodies aggravates colitis in G alpha i2-deficient mice. Eur. J. Immunol. 35: 2274-2283.
37. Bowden, R.A., Z.M. Ding, E.M. Donnachie, et al. 2002. Role of alpha4 integrin and VCAM-1 in CD18-independent neutrophil migration across mouse cardiac endothelium. Circ. Res. 90: 562-569.
38. Podolsky, D.K., R. Lobb, N. King, et al. 1993. Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody. J. Clin. Invest. 92: 372-380.
39. Podolsky, D.K. 2005. Selective adhesion-molecule therapy and inflammatory bowel disease-a tale of Janus? N. Engl. J. Med. 353: 1965-1968.
40. Schneider, M.K., M. Strasser, U.O. Gilli, et al. 2002. Rolling adhesion of human NK cells to porcine endothelial cells mainly relies on CD49d-CD106 interactions. Transplantation 73: 789-796.
41. Rutgeerts, P., S. van Deventer & S. Schreiber. 2003. Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease-focus on selective adhesion molecule inhibition. Aliment. Pharmacol. Therap. 17: 1435-1450.
42. Rutgeerts, P., S. Vermeire & G. Van Assche. 2009. Biological therapies for inflammatory bowel diseases. Gastroenterology 136: 1182-1197.
43. Spahn, T.W., H.L. Weiner, P.D. Rennert, et al. 2002. Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur. J. Immunol. 32: 1109-1113.
44. Worbs, T., U. Bode, S. Yan, et al. 2006. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J. Exp. Med. 203: 519-527.
45. Spahn, T.W., H. Herbst, P.D. Rennert, et al. 2002. Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches. Am. J. Pathol. 161: 2273-2282.
46. Dohi, T., P.D. Rennert, K. Fujihashi, et al. 2001. Elimination of colonic patches with lymphotoxin beta receptor-Ig prevents Th2 cell-type colitis. J. Immunol. 167: 2781-2790.
47. Makita, S., T. Kanai, Y. Nemoto, et al. 2007. Intestinal lamina propria retaining CD4+CD25+ regulatory T cells is a suppressive site of intestinal inflammation. J. Immunol. 178: 4937-4946.